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An investigation into the
prescribing of analgesics
I. Truter, T. J. van W. Kotze
Objective. To investigate the prescribing of analgesic
agents in a defined South African patient population.
Design. Retrospective drug utilisation study.
Setting. Prescribing behaviour of a sample of 50
dispensing doctors in Port Elizabeth. Data were obtained
from a medical aid which used a formulary system.
Main outcome measures. Percentage of" central nervous
system drugs that analgesics comprised; proportion of
patients using combination analgesics; cost of analgesics.
Results. On average, 83.3% of all central nervous
system drugs dispensed were analgesic agents. These
agents represented 70.9% of the total cost of central·
nervous system drugs. A high percentage (82.2%) of the
analgesic agents dispensed were combination or
polycomponent analgesics. The combination analgesic
tablet, consisting of paracetamol, meprobamate, caffeine
and codeine phosphate, was the most frequently
prescribed central nervous system drug. This product
accounted on average for 40.4% of all analgesics
dispensed. Nearly half (46.0%) of all the analgesics
dispensed by the sample of doctors were available
without a prescription.
Conclusion. The high prescribing rate of combination
analgesic prescription was a cause for concern, given the
dependence-producing potential of some of the
ingredients, e.g. meprobamate. The prescribing and use of
analgesics should be carefully monitored by further drug
utilisation studies in light of the serious adverse effects,
such as analgesic nephropathy, associated with the long-
tenn use of these agents.
S Afr Med J 1996; 86: 1394-1397.
Pain is the most common of all medical complaints.! Pain
relief is therefore one of the most vital services rendered by
physicians.:2 Various ways to obtain pain relief have been
used over the years. Analgesic agents, however, form the
cornerstone of treatment for pain. Under the usual clinical
circumstances, the general practitioner attempts to provide
analgesia by orally administered medication, choosing from
the multitude of prescription and over-the-counter
preparations that line pharmacists' shelves. When
administered in the proper setting and used rationally, these
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agents are very safe. Analgesic agents, however, have
covert dangers when used chronically and in higher dosages
than those indicated. In South Africa in 1983, 21% of
patients on renal dialysis in Johannesburg Hospital had a
history of analgesic abuse.3
There is a wide variety of analgesic agents available in
South Africa. Many of these are combination or
polycomponent preparations, Le. products that contain in
their formulation various adjuvants such as codeine,
caffeine, propoxyphene, meprobamate and chlormezanone.
In 1993, there were more than 100 combination analgesics
in tablet and capsule form available from retail pharmacies in
South Africa.~ Numerous arguments have been advanced
both in favour of and in opposition to the prescription of
fixed-ratio drug combinations.3 With regard to analgesic
combinations in particular, various rationales for their use
have been identified.s Most combinations are formulated
with two main rationales in mind, viz. enhancement of
analgesia and reduction of adverse effects. This is achieved
by the combination of two analgesics with different
mechanisms of action. These drugs may also improve
patient compliance and generally provide ingredients at a
lower cost than if the ingredients were prescribed separately.
However, a number of arguments exist against the use of
fixed-ratio analgesic combinations. The most important of
these are that combinations limit flexibility and
individualisation of dosage, and that combination analgesics
may expose patients to ingredients not necessary for pain
relief in their particular condition.5
Analgesics are one of the most frequently prescribed drug
groups.' Yet, according to Gustafsson and Boethius,8
epidemiological studies of the utilisation of analgesics are
few, in spite of their wide use as single and fixed
combinations.
The primary aim of this study was therefore to investigate
the prescribing patterns of a group of doctors in Port
Elizabeth in respect of analgesic agents. Since no previous
drug utilisation studies on analgesic prescribing had been
pertormed on this doctor sample, it was necessary first to
determine the overall drug prescribing pattern. This was
done by means of a broad retrospective drug utilisation
study. Thereafter, the prescribing of analgesic agents was
investigated in more detail.
Subjects and methods
Prescription data from 50 dispensing doctors, out of a total
population of 138 dispensing doctors, serving a
homogeneous non-affluent patient population in a well-
demarcated geographical area in Port Elizabeth, were
analysed retrospectively. The study was carried out over 4
months in a period of 1 year (July 1992, October 1992,
January 1993 and April 1993) to detect and account for any
possible seasonal effects. The 50 doctors served on average
50 246 registered patients of a medical aid during the period
of the stUdy.
The study can be classified as a broad retrospective drug
utilisation study with the emphasis on the prescribing of
analgesic agents. The study was mainly quantitative. No
diagnoses were available; therefore very few comments
could be made on the quality of care.
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The doctors in the study used a formulary containing 450
drugs. Since, on average. 93.6% of all the drugs issued by
this group of dispensing' doctors were formulary drugs, it
was decided to focus on formulary drugs in the drug
utilisation study. Analgesics were classified under central
nervous system drugs.
Results and discussion
A general drug utilisation study was performed to determine
the frequency and cost of analgesic prescribing in relation to
total prescribing. Central nervous system drugs were the
most frequently dispensed therapeutic type, accounting on
average for 24.9% of all formulary drugs dispensed. Central
nervous system drugs accoun!ed for only 13.6% of the
average cost of formulary drugs dispensed and were
therefore relatively inexpensive as a group.
Dispensing of central nervous system
drugs
Eighty-eight of the 450 drugs in the formulary (19.6%) were
classified as central nervous system drugs. These
accounted on average for 24.9% of all formulary drugs
dispensed.
The central nervous system drugs in the formulary were
classified into seven therapeutic subgroups, viz. hypnotics
and anxiolytics, drugs used for psychoses and related
disorders, antidepressant drugs, drugs used for nausea and
vertigo, analgesics, anti-epileptics and drugs used for
Parkinsonism-related disorders.
The average percentage of drugs dispensed in each of
these subgroups is given in Table l. Analgesics accounted
on average for 83.3% of the total number of formulary
central nervous system drugs dispensed. It is interesting to
note that the most prescribed central nervous system
subgroup (analgesics) is classified under 'symptomatic
prescribing' in the teleological classification developed by
McGavock et al. 9 These drugs relieve symptoms with little or
no effect on the disease process. No definite seasonal
variations were detected in the prescribing of the different
central nervous system therapeutic subgroups.
,
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Table 11. The 10 formulary central nervous system drugs that were
on average the most frequently dispensed
1 ParacetamoVmeprobamateJcaffeine/codeine phosphate tablets
2 ParacetamoVmeprobamate/codeine phosphate capsules
3 Paracetamol syrup
4 ParacetamoVcodeine phosphate tablets
5 ParacetamoVpromethazine/codeine phosphate syrup
6 Aspirin/codeine phosphate tablets
7 Paracetamol tablets
8 Diazepam 5 mg tablets
9 Metoclopramide 10 mg tablets
10 ParacetamoVchlormezanone tablets
The analgesic subgroup also accounted for the highest
average cost per month. If the seven central nervous system
subgroups are considered, analgesics accounted on
average for 70.9% of the total cost of all central nervous
system drugs dispensed.
The percentage of all formulary central nervous system
drugs that analgesic products represent per doctor for July
1992 is illustrated in a histogram in Fig. 1. A similar pattern
was observed for the other 3 months of the study. During all
4 months, the modal frequency occurred between 80.0%
and 89.9%.
Fig. 1. Distribution of analgesics as a percentage of total central
nervous system formulary items per doctor for July 1992.
The paired two-sample t-tests for means for sequential
months were used to determine whether differences existed
between months. No differences were found. It can be
expected that if all calendar months were included in the
study such differences could have been observed.
•
Table 1. Average percentage of formulary drugs dispensed in each
central nervous system subgroup
An analysis was also made of the 10 central nervous
system drugs on the formulary that were on average the
most frequently dispensed (Table 11). The first 7 products
listed were all analgesic preparations.
Hypnotics and anxiolytics
Drugs used in psychoses and related disorders
Antidepressant drugs
Drugs used in nausea and vertigo
Analgesics
Anti-epileptics
Drugs used in Parkinsonism-related disorders
Total
9.03
0.10
1.29
5.94
83.25
0.39
0.00
100.00
Dispensing of analgesic products
Thirteen products on the formulary were classified as
analgesic preparations. These products are listed in Table Ill.
Note that codeine phosphate (30 mg) was classified as an
analgesic for the purposes of this study (codeine phosphate
30 mg is classified as an opioid analgesic in the British
National Formulary!'. It must, however, be noted that it can
also be used as an antidiarrhoeal drug.
The 13 analgesics in the formulary accounted on average
for 83.3% of the total number of formulary central nervous
system drugs dispensed. An analysis was made to
determine the prescribing rate of each analgesic. The
average percentage of each formulary analgesic dispensed
is given in Table Ill. The combination (or polycomponent)
analgesic tablet, consisting of paracetamol, meprobamate,
caffeine and codeine phosphate, was the most frequently
prescribed central nervous system drug. This product
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accounted on average for 40.4% of the total number of
analgesics dispensed.
Table Ill. Average percentage of each formulary analgesic
dispensed
Codeine phosphate 30 mg tablets
Aspirin 300 mg tablets
Aspirin soluble 300 mg tablets
Paracetamol 500 mg tablets
Paracetamol syrup
Aspirin/codeine phosphate tablets
ParacetamoVmeprobamate/caffeine/codeine
phosphate tablets
Paracetamol/meprobamate/codeine phosphate capsules
ParacetamoVcodeine phosphate tablets
Paracetamol/chlonnezanone tablets
Paracetamol/promethazine/codeine phosphate syrup
Paracetamol/codeine phosphate syrup
Propoxyphene/paracetamol capsules
Total
0.25
0.10
0.05
4.82
12.61
7.99
40.42
13.26
10.58
1.73
8.00
0.12
0.07
100.00
dependence-producing potential of some of the ingredients
as well as the possibility of nephropathy.
One combination analgesic, viz. the combination of
paracetamol, meprobamate, caffeine and codeine
phosphate tablets, represented on average nearly half
(49.2%) of all the combination analgesics dispensed.
Cost of analgesic products dispensed
The 10 analgesics that accounted for the highest average
cost per month are given in Table IV. The central nervous
system drug most frequently dispensed (the combination
analgesic tablet consisting of paracetamol, meprobamate,
caffeine and codeine phosphate) also accounted for the
highest average cost per month of all the central nervous
system drugs dispensed. This represented 20.7% of the
total cost of all central nervous system drugs dispensed.
The 4 analgesics that accounted for the highest average
cost per month were together responsible for more than
50% of the total cost of all central nervous system drugs
(Table IV).
Table IV. The 10 analgesics that accounted for the highest
average cost per month
Analgesic agents form the cornerstone of treatment of pain.
Yet, their usefulness for minor aches and pains is debatable.
The perception of pain varies greatly between individuals,
and within one person in differing circumstances. It must
also be kept in mind that analgesics provide only
symptomatic relief and do not influence the actual disease
process.
The results of this drug utilisation study clearly showed
that there was an overuse of analgesic agents, specifically
combination analgesic agents. We concluded that
approximately 83% of all central nervous system items
dispensed by this group of doctors were analgesic agents.
Since no diagnosis was available, it is difficult to explain the
exact reasons for this high analgesic prescribing rate.
However, if the low prescription rate of other central nervous
system drugs is taken into account, the question can be
asked whether this group of doctors treated anxiety and
This drug was followed by a similar combination analgesic
(consisting also of paracetamol, meprobamate and codeine
phosphate, but without caffeine, and in a slightly different
combination). This product was in capsule form.
These two combination analgesics containing
meprobamate are classified as schedule 5 substances in
South Africa. Products containing meprobamate are,
however, classified as controlled drugs by the British
National Formulary.la In other words, the total quantity of the
preparation, or the number of dose units, must be written in
both words and figures in the prescriber's own handwriting.
This is equivalent to a schedule 7 drug in South Africa, and
is therefore subject to greater control than a schedule 5
drug.
It is interesting to note that the two analgesics that
consisted only of aspirin (aspirin 300 mg and aspirin 300 mg
soluble tablets) were infrequently dispensed. The analgesics
containing paracetamol were more popular than those
containing aspirin. No significant seasonal variations in
analgesic prescribing were detected.
Nine of the 13 analgesics listed in the formulary were
available without a prescription from a doctor. These 9
products accounted on average for 46% of all analgesics
dispensed. Patients could therefore have bought nearly half
of the total number of analgesics dispensed from a retail
pharmacy without a prescription.
An important finding of the study was that there was a
clear tendency for doctors to show a preference for certain
brand names. For these particular brand names, the 50
doctors displayed clustering that was confirmed by means
of a chi-square test.
Dispensing of combination analgesic
preparations
Eight of the 13 analgesics in the formulary were combination
analgesics. These 8 represented on average 82.2% of all
analgesics dispensed. The high prescribing rate of
combination analgesics was a cause for concern given the
Paracetamol/meprobamate/caffeine/
codeine phosphate tablets
Paracetamol/meprobamate/codeine
phosphate capsules
Paracetamol syrup
Paracetamol/codeine phosphate tablets
Aspirin/codeine phosphate tablets
Paracetamol/promethazine/codeine
phosphate syrup
Paracetamol/chlonnezanone tablets
Codeine phosphate 30 mg tablets
Paracetamol 500 mg tablets
Paracetamol/codeine phosphate syrup
Conclusion
Average
cost
(rands)
16080.67
8352.19
8324.84
6983.05
6416.38
6411.30
891.34
655.22
636.94
128.20
Cost
contribution
to eNS
drugs (%)
20.73
10.76
10.73
9.00
8.27
8.26
1.15
0.84
0.82
0.17
1396 Volume 86 No.11 November 1996 SAMJ
depression with analgesrcs rather than with the recognised
drugs for these disease states. The fact that the most
frequently prescribed analgesic was a combination product
containing meprobamate. a substance well known for its
dependence-producing potential, is a serious cause for
concern.
Furthermore, since nearly half (46%) of all analgesics
dispensed by the sample of doctors were available without a
prescription, it can be asked whether these patients did not
abuse their medical aid. All products in the formulary were
provided to patients free of charge. If they had bought these
products at a retail pharmacy, the normal retail price would
have been charged.
The responsibility for educating the public on the correct
use of medicine rests with the custodians of medicines, viz.
doctors and pharmacists. If they do not prescribe and
dispense these medicines rationally, there is little chance
that the public will use these products rationally. Although
the results of this study were in agreement with general
expectations (following discussion of the results with various
local practitioners), it must be emphasised that the results
can be interpreted only in terms of the patient population
and methodology employed. Specifically, they cannot be
extrapolated to the local retail pharmacy situation. A logical
next step will be to undertake a further drug utilisation study
to determine the sales of non-prescription single-component
analgesics and combination analgesics by retail pharmacies,
and also to investigate the demographic characteristics of
analgesic users.
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A drug utilisation study
investigating prescribed
daily doses of
hypolipidaemic agents
I. Truter, T. J van W. Kotze
Objectives. To estimate average prescribed daily doses
(PODs) for selected hypolipidaemic agents available on
the South African market. Comparison of the estimated
PODs with established ODDs (defined daily doses) and
international dosage ranges. To investigate the age and
gender of the users of the different hypolipidaemic drugs
and drug groups.
Design. Retrospective drug utilisation study using data
from an organisation involved in the pre-certification of
chronic medication.
Setting. Doctors and patients in South Africa.
Participants. A total of 2 336 patients of various medical
aids who were using cholesterol-lowering medication on a
chronic basis.
Outcome measures. The PODs, for the complete sample
and for the age and gender groups.
Results. More than 90% of all hyperlipidaemic patients
in the study were treated with HMG CoA reductase
inhibitors or fibrates. The average PODs for the three most
frequently prescribed lipid-lowering drugs were 414.4 mg
for bezafibrate, 12.5 mg for pravastatin and 12.6 mg for
simvastatin. The PODs were on average lower than the
established ODDs. Differences were observed in the
pattern of lipid-lowering drug prescriptions for women and
men. Male users were on average 3.9 years younger than
female users.
Conclusions. The PODs used in the patient population
studied were within locally and internationally acceptable
dosage ranges, but were generally lower than established
ODDs for lipid-lowering drugs. Prescription differences
exist between female and male patients and between age
groups with regard to chronic medication. Further studies
should be conducted to investigate hypolipidaemic drug
prescribing in patients who are not on chronic medication.
S Afr Med J 1996 86: ,397·"<10'
Various methods exist to measure drug consumption. The
traditional measures, viz. volume and cost, have inherent
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